Trinity Biotech Q3 2022 Earnings Preview
- Trinity Biotech (NASDAQ:TRIB) is scheduled to announce Q3 earnings results on Thursday, December 15th, before market open.
- The consensus EPS Estimate is -$0.04 and the consensus Revenue Estimate is $19.5M (-11.4% Y/Y).
- Over the last 2 years, TRIB has beaten EPS estimates 63% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 1 downward.